Millions of deep vein thrombosis survivors develop post-thrombotic syndrome, a chronic condition causing leg pain, swelling, and reduced mobility that significantly impacts quality of life. Despite widespread use of endovascular procedures to restore blood flow, rigorous evidence supporting their effectiveness has been limited.
This randomized controlled trial enrolled 284 patients with moderate to severe post-thrombotic syndrome and compared endovascular therapy plus standard care against standard care alone over 24 months. The endovascular group underwent procedures including balloon angioplasty and stent placement to address venous obstructions. Primary outcomes measured symptom severity using validated scoring systems, while secondary endpoints assessed quality of life metrics and functional capacity.
Results demonstrated no significant difference between groups in symptom improvement or quality of life measures. Both treatment arms showed similar rates of leg pain, swelling, and mobility limitations at follow-up assessments. Complication rates in the endovascular group included procedural risks and stent-related issues, though serious adverse events remained relatively low.
This finding challenges current clinical practice where endovascular interventions are increasingly performed for post-thrombotic syndrome management. The cardiovascular community has embraced these procedures based on observational studies and mechanistic reasoning, but this represents the first adequately powered randomized trial to rigorously test the approach. The results suggest that opening blocked veins may not translate to meaningful clinical benefit for patients, possibly due to irreversible valve damage or collateral circulation already compensating for obstructions. This evidence should prompt clinicians to reconsider patient selection criteria and potentially reserve these invasive procedures for more carefully defined subgroups.